Director/PDMR Shareholding

RNS Number : 2225N

Reckitt Benckiser Group PLC

21 October 2016

 

21 October 2016

RECKITT BENCKISER GROUP PLC

("RB" or the "Company")

 DIRECTOR/PDMR SHAREHOLDING

Notification of transactions of Directors/Persons Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

The Company was notified on 21 October 2016 that Adrian Hennah, Chief Financial Officer, purchased 8,959 Shares on the same day at a price of £72.18705 per share. 

Following this purchase, Mr Hennah's shareholding has increased to 65,397 Shares, representing 0.0093% of the Company's total voting rights.

The following notification is made in accordance with the requirements of the EU Market Abuse Regulation.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY  PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Adrian Hennah
2	Reason for the notification
a)	Position/status	Chief Financial Officer, a Director and PDMR
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Reckitt Benckiser Group plc
b)	LEI	5493003JFSMOJG48V108
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 10p each in Reckitt Benckiser Group plc ("Shares") GB00B24CGK77
b)	Nature of the transaction	Purchase of Shares in the Company
c)	Price(s) and volume(s)	Price(s) Volume(s) GBP 72.18705 8,959
d)	Aggregated information -       Aggregated volume -       Price	8,959  GBP 72.18705
e)	Date of the transaction	2016-10-21
f)	Place of the transaction	London Stock Exchange, Main Market - XLON

For further Information:
Christine Logan

Company Secretary
Tel [phone]

About RB:

RB* is the world's leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe. The company employs approximately 37,000 people worldwide.

Inspired by a purpose to deliver innovative solutions for healthier lives and happier homes, RB is in the top 20 companies listed on the London Stock Exchange. We are the global No 1 or No 2 in the majority of our fast-growing categories, driven by an exceptional focus on innovation. Our health, hygiene and home portfolio is led by our global Powerbrands including Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French's. Our Powerbrands represent 80% of net revenue.

RB is redefining the world of consumer health and hygiene. Our people and unique culture are at the heart of our success. We have a drive for achievement and a passion to outperform wherever we focus, including sustainability where we are targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and 1/3 of net revenue from more sustainable products. We are proud to be Save the Children's largest global partner, with a new vision to radically reduce one of the world's largest killers of under 5s, diarrhoea. 

For more information visit www.rb.com 

*RB is the trading name of the Reckitt Benckiser group of companies

 

END

 

 

DSHBUBDGXUDBGLB